Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2007 10:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Licensing/Research Agreements On Ampligen as Influenza Adjuvant With Japan's BIKEN

PHILADELPHIA, Dec. 13, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has concluded an agreement with a major vaccine manufacturer in Japan for the use of the...
December 10, 2007 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Intends to Terminate License to Esteve for the Marketing of Ampigen for Chronic Fatigue Syndrome in Certain Territories

PHILADELPHIA, Dec. 10, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that it has notified Laboratorios Del Dr. Esteve, S.A. ("Esteve") of its intention to terminate the...
December 08, 2007 16:13 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Investors Conference Call

PHILADELPHIA, Dec. 8, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an investor conference call and webcast to take place on Monday, December 10,...
December 07, 2007 17:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Receives Notice of Incomplete New Drug Application (NDA)

PHILADELPHIA, Dec. 7, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that it has received notice from the U.S. Food and Drug Administration (FDA) that its NDA submission for...
December 06, 2007 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present At the NYSSA 11th Annual Biotech/Specialty Pharma Conference

PHILADELPHIA, Dec. 6, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that Anthony Bonelli, President and Chief Operating Officer of Hemispherx, will be presenting at...
November 29, 2007 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Change in Audit Committee

PHILADELPHIA, Nov. 29, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) On November 20, 2007 Steven D. Spence submitted his resignation from the Board of Directors effective immediately....
November 12, 2007 09:00 ET | Source: Hemispherx Biopharma, Inc.

Japan Institute of Infectious Diseases Publishes Second Article On Ampligen as Avian Flu Vaccine Immune Enhancer

PHILADELPHIA, Nov. 12, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that its collaborative partner, Japan's National Institute of Infectious Diseases (JNIID), has published...
November 08, 2007 11:36 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Interim Financial Results for the Three Months Ended September 30, 2007

PHILADELPHIA, Nov. 8, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its interim financial results for the three months ended September 30, 2007. The net loss for this fiscal...
October 31, 2007 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Presents At Rodman & Renshaw 9th Annual Healthcare Conference

PHILADELPHIA, Oct. 31, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB), today announced plans to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. On...
October 18, 2007 10:00 ET | Source: Hemispherx Biopharma, Inc.

Japan Institute of Infectious Diseases Publishes Article On Ampligen as Avian Flu Vaccine Immune Enhancer

PHILADELPHIA, Oct. 18, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that its collaborative partner, Japan's National Institute of Infectious Diseases (JNIID), has published...